Viking Therapeutics, Inc.

Historical 13F Holders

Symbol
VKTX
CUSIP
92686J106
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 92686J106 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
5.1% 11/5/2025
Event 9/30/2025
Vanguard Capital Management LLC 13G 5.1% 4/30/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
BlackRock, Inc. 13G/A 4.5% 4/23/2025
Event 3/31/2025
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 28 632 k $20.5 M
2026 Q2 477 80.8 M $3.08 B
2026 Q1 446 73.3 M $2.43 B
2025 Q4 473 72.1 M $2.54 B
2025 Q3 413 73.8 M $1.94 B
2025 Q2 438 77.1 M $2.04 B
2025 Q1 418 78.1 M $1.89 B
2024 Q4 458 82.0 M $3.30 B
2024 Q3 475 86.3 M $5.40 B
2024 Q2 446 83.7 M $4.43 B
2024 Q1 441 83.5 M $6.84 B
2023 Q4 229 79.6 M $1.48 B
2023 Q3 207 77.4 M $857 M
2023 Q2 225 75.0 M $1.22 B
2023 Q1 218 66.8 M $1.11 B
2022 Q4 150 34.4 M $322 M
2022 Q3 114 26.6 M $72.4 M
2022 Q2 124 26.7 M $77.3 M
2022 Q1 153 31.1 M $93.9 M
2021 Q4 153 36.6 M $168 M
2021 Q3 141 37.8 M $238 M
2021 Q2 146 37.9 M $227 M
2021 Q1 154 41.0 M $260 M
2020 Q4 161 38.2 M $215 M
2020 Q3 156 39.6 M $230 M
2020 Q2 156 40.2 M $290 M
2020 Q1 156 39.5 M $185 M
2019 Q4 162 40.7 M $326 M
2019 Q3 163 40.7 M $280 M
2019 Q2 185 46.4 M $385 M
2019 Q1 191 45.9 M $456 M
2018 Q4 188 47.8 M $366 M
2018 Q3 181 43.8 M $763 M
2018 Q2 129 31.8 M $302 M
2018 Q1 69 20.9 M $91.4 M
2017 Q4 33 9.34 M $37.9 M
2017 Q3 18 2.02 M $3.85 M
2017 Q2 12 1.57 M $1.69 M
2017 Q1 13 771 k $1.13 M
2016 Q4 13 652 k $777 k
2016 Q3 14 1.21 M $1.70 M
2016 Q2 13 861 k $1.08 M
2016 Q1 11 46.5 k $72.0 k
2015 Q4 7 44.4 k $158 k
2015 Q3 6 43.2 k $252 k
2015 Q2 6 54.0 k $384 k